These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23734707)

  • 1. The human ΔNp53 isoform triggers metabolic and gene expression changes that activate mTOR and alter mitochondrial function.
    Lin SC; Karoly ED; Taatjes DJ
    Aging Cell; 2013 Oct; 12(5):863-72. PubMed ID: 23734707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Δ40p53 isoform inhibits p53-dependent eRNA transcription and enables regulation by signal-specific transcription factors during p53 activation.
    Levandowski CB; Jones T; Gruca M; Ramamoorthy S; Dowell RD; Taatjes DJ
    PLoS Biol; 2021 Aug; 19(8):e3001364. PubMed ID: 34351910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos.
    Davidson WR; Kari C; Ren Q; Daroczi B; Dicker AP; Rodeck U
    BMC Dev Biol; 2010 Oct; 10():102. PubMed ID: 20929554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DeltaNp53 or p44: priming the p53 pump.
    Scrable H; Sasaki T; Maier B
    Int J Biochem Cell Biol; 2005 May; 37(5):913-9. PubMed ID: 15743665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-R273H Sustains ROS, Pro-Inflammatory Cytokine Release and mTOR Activation While Reducing Autophagy, Mitophagy and UCP2 Expression, Effects Prevented by wtp53.
    Romeo MA; Gilardini Montani MS; Benedetti R; Arena A; D'Orazi G; Cirone M
    Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33668399
    [No Abstract]   [Full Text] [Related]  

  • 6. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy.
    Bristow RG; Benchimol S; Hill RP
    Radiother Oncol; 1996 Sep; 40(3):197-223. PubMed ID: 8940748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown.
    Puca R; Nardinocchi L; Gal H; Rechavi G; Amariglio N; Domany E; Notterman DA; Scarsella M; Leonetti C; Sacchi A; Blandino G; Givol D; D'Orazi G
    Cancer Res; 2008 May; 68(10):3707-14. PubMed ID: 18483253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells.
    Liang Y; Besch-Williford C; Benakanakere I; Hyder SM
    Int J Oncol; 2007 Oct; 31(4):777-84. PubMed ID: 17786308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased mTOR activity and metabolic efficiency in mouse and human cells containing the African-centric tumor-predisposing p53 variant Pro47Ser.
    Gnanapradeepan K; Leu JI; Basu S; Barnoud T; Good M; Lee JV; Quinn WJ; Kung CP; Ahima R; Baur JA; Wellen KE; Liu Q; Schug ZT; George DL; Murphy ME
    Elife; 2020 Nov; 9():. PubMed ID: 33170774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells.
    Cuddihy AR; Jalali F; Coackley C; Bristow RG
    Mol Cancer Ther; 2008 Apr; 7(4):980-92. PubMed ID: 18413811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Δ40p53 is involved in the inactivation of autophagy and contributes to inhibition of cell death in HCT116-Δ40p53 cells.
    Zang Y; Shi Y; Liu K; Qiao L; Guo X; Chen D
    Oncotarget; 2017 Feb; 8(8):12754-12763. PubMed ID: 28061446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status.
    Nagata Y; Takahashi A; Ohnishi K; Ota I; Ohnishi T; Tojo T; Taniguchi S
    Int J Oncol; 2010 Oct; 37(4):1001-10. PubMed ID: 20811722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas.
    Snijders AM; Liu Y; Su L; Huang Y; Mao JH
    Oncotarget; 2015 Dec; 6(42):44794-805. PubMed ID: 26575021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours.
    Habib NA; Hodgson HJ; Lemoine N; Pignatelli M
    Hum Gene Ther; 1999 Aug; 10(12):2019-34. PubMed ID: 10466636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein.
    Vinyals A; Peinado MA; Gonzalez-Garrigues M; Monzó M; Bonfil RD; Fabra A
    Gene Ther; 1999 Jan; 6(1):22-33. PubMed ID: 10341872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of cooperation of tumor suppressor p33(ING1b) with p53 gene in hepatocellular carcinoma].
    Zhu Z; Lin J; Qu JH; Li FM; Ni CR; Zhu MH
    Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1795-800. PubMed ID: 14642087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53.
    Shin S; Jing K; Jeong S; Kim N; Song KS; Heo JY; Park JH; Seo KS; Han J; Park JI; Kweon GR; Park SK; Wu T; Hwang BD; Lim K
    Biomed Res Int; 2013; 2013():568671. PubMed ID: 23841076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.
    Iyer SV; Parrales A; Begani P; Narkar A; Adhikari AS; Martinez LA; Iwakuma T
    Oncotarget; 2016 Feb; 7(5):5401-15. PubMed ID: 26700961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of mitochondria in mTOR-regulated longevity.
    Wei Y; Zhang YJ; Cai Y; Xu MH
    Biol Rev Camb Philos Soc; 2015 Feb; 90(1):167-81. PubMed ID: 24673778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild-type p53 binds to MYC promoter G-quadruplex.
    Petr M; Helma R; Polášková A; Krejčí A; Dvořáková Z; Kejnovská I; Navrátilová L; Adámik M; Vorlíčková M; Brázdová M
    Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27634752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.